[Impact of integrated asthma treatment on the patients' quality of life].
BACKGROUND
Patient's perception about the effect of disease's manifestations on daily activities is called health-related quality of life, and it is used to evaluate the individual response to treatment. At present, there are some questionnaires designed to evaluate it.


OBJECTIVE
To evaluate the effect of integral treatment dosage on quality of life in asthmatic adults.


METHODS
A prospective, longitudinal and experimental study was made. We included male and female adult patients, with allergic asthma. A standardized questionnaire of quality of life was applied to all of them in every visit, for eight times. The integral treatment was based on Global Initiative for Asthma judgments.


RESULTS
Ten patients were included, 70% of them were women. The media age was 37.4 +/- 15.73 years old. The asthma was diagnosed as intermittent in 10% cases, mild persistent in 20%, moderate persistent in 20% and severe persistent in 50% patients. The group of age most frequently affected was that of 20 to 30 years old. The media index of quality of life was 2.43 +/- 0.91 at the first visit and it was 5.73 +/- 1.11 at eighth visit. It was found a significant difference.


CONCLUSIONS
Integral treatment improves quality of life in asthmatic adults.
Salazar Aguilar
Alfredo Ariel
AA
Servicio de alergia e inmunología clínica, Hospital Universitario de Puebla, Benemérita Universidad Autónoma de Puebla. asalazar@mail.medinet.net.mx
López García
Aída Inés
AI
Paz Martínez
David
D
Galindo García
José Arturo
JA
Martínez Olivares
Ricardo
R
Papaqui Tapia
Sergio
S
D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000523:psychology / Q000628:therapy*; D019090:Case Management; D003131:Combined Modality Therapy; D003888:Desensitization, Immunologic; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009316:National Institutes of Health (U.S.); D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D011788:Quality of Life; D012129:Respiratory Function Tests; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D014481:United States; D014944:World Health Organization
D018927:Anti-Asthmatic Agents